Longwood Healthcare Leaders meetings are invitation-only forums typically held at leading academic institutions. Biopharma CEOs, heads of R&D, academic researchers, and healthcare investors join off-the-record discussions that generate new company ideas and approaches for Longwood Fund and members of our biopharma ecosystem, creating strategic business opportunities to advance the industry and bring important medicines to patients in need.
Longwood Healthcare Leaders的外部链接
US，MA，Boston，02199
Miami CEO convenes senior industry executives for an annual leadership summit on Key Biscayne with valuable discussion and networking opportunities, including an evening out for sunset cocktails and dinner at the Key Biscayne Yacht Club. To request an invitation, email?[email protected].
此处无法显示此内容
在领英 APP 中访问此内容等
Miami CEO convenes a limited number of biopharma CEOs, investors, and researchers for unique networking opportunities and off-the-record discussion with leaders in the industry at The @RitzCarlton Key Biscayne. https://conta.cc/3YXkSeX
Longwood Healthcare Leaders转发了
I recently participated in a compelling panel on the connection between health equity and patient impact as part of Longwood Healthcare Leaders annual Boston CEO event. We discussed a range of issues including how Takeda has evolved its go-to-market model globally to help patients overcome barriers to accessing the care and treatments they need, especially in low and middle-income countries.?? ? We also addressed the growing challenges healthcare systems are facing around affordability, sustainability, and equity. This includes evolving traditional commercial business models to help strengthen local healthcare systems, including diagnosis and provider training, digital and AI-assisted tools, tiered pricing, and affordability-based patient assistance programs.?? These approaches are critically important to ensuring that every person who needs our medicines has access.??? ?? Thanks to Longwood Healthcare Leaders for organizing this important forum and to my fellow panelists Gavin MacBeath, Anna Kazanchyan, M.D. and Deborah C. Mash for an engaging and thought-provoking conversation! The shared dedication and focus on improving health equity around the world was truly inspiring.?? ?? #healthequity #accesstomedicines?
Longwood Healthcare Leaders转发了
Forging the Future: Can we unite industries for truly transformative innovations? What an exciting chat at the Boston CEO! It was a privilege to engage in a dynamic conversation with Fiona H. Marshall, President of Biomedical Research at Novartis, moderated by Kailash Swarna, Managing Director at Accenture, and Christoph Westphal, General Partner at the Longwood Fund. This was the Longwood Healthcare Leaders meeting that brought together over 200 industry leaders, including C-suite executives, R&D heads, academic researchers, and life science investors. We delved into the core of sustainable R&D, exploring the transformative power of partnerships in driving genuine innovation and creation. How can we cultivate and sustain collaborations to develop superior health solutions, moving beyond competition to collective progress? We also explored core values and pivotal strategic decisions that have allowed Novo Nordisk to maintain its innovative edge over the years. Moreover, we contemplated the crucial role of R&D in ensuring accessibility to groundbreaking pharmaceuticals, addressing the vital need for equitable healthcare access. It’s impossible to know what is in the future but leveraging our current knowledge and the latest data science advancements, we looked ahead and reflected jointly on how the landscape will evolve, and how can the convergence of technology and biopharma unleash the potential of AI in drug discovery and development? This is an exciting journey, and we are at the forefront of shaping the future. I am truly energized by the insights shared amongst the participants. Hopefully, this is just the beginning of a transformative era, one where collaboration and innovation will redefine the very fabric of healthcare. Watch this space for the remarkable evolution that awaits us! #Innovation #Collaboration #longwoodhealthcareleaders #BostonCEO
Just ahead of #JPM2025, join leaders in the industry for a 2-day networking and discussion forum?at Four Seasons Hotel San Francisco, the Saturday and Sunday immediately prior to #JPMweek. See details:?https://conta.cc/40A8jbP
Longwood Healthcare Leaders转发了
A little late in posting but I had a blast in Boston a couple weeks ago at the Boston CEO Summit! It was great to meet and reconnect with many CEOs and executives, and leaders in biopharma, including a very strong presence of those of us in the biotech CEO sisterhood! Thanks to Longwood Healthcare Leaders for hosting. Having grown up in Massachusetts and New York, I have to say I love coming back and am so impressed with the Boston biotech and R&D ecosystem... can definitely see myself on the east coast in the near future ;) Enjoyed representing Juvena Therapeutics on a terrific panel that focused on leveraging the latest innovations in technologies and AI and its impact on drug discovery and development across?#biopharma, alongside Ashley Zehnder, Kai Wucherpfennig, Jason Cole, and moderator Chandra Ramanathan.
We were honored to feature Brad Margus in a non-profit spotlight at Boston CEO last week as he shared the important work he and the @atchildrensproject are doing to advance research in #ataxiatelangiectasia and #genetherapy. See his call for researchers below and spread the word about this important initiative. https://atcp.org/
Co-founder & Board Chair at Cerevance | Founder & Volunteer Chair at A-T Children's Project
I still need your help persuading gene therapy experts to spend a few hours with us! Just twelve days from now, scientists, clinicians, and drug developers from around the world will gather in Boston to explore gene therapy approaches for treating my sons' devastating disease, ataxia telangiectasia (A-T). It robs kids of muscle control, balance, speech, swallowing and eye-tracking, while also causing immune deficiencies, lung problems, and a high cancer risk. After reviewing A-T's symptoms, cellular phenotype, and the mutated ATM gene, we'll review efforts now underway to develop and test antisense oligonucleotide (ASO) therapies in A-T kids who have specific mutations that can be addressed with this approach. BUT WE URGENTLY NEED EXPERTS IN OTHER APPROACHES BEYOND ASOs! We’re seeking insights into gene delivery options—AAV, lentivirus, non-viral, and dual-vector strategies (the ATM gene is large)—along with advanced gene editing techniques, including CRISPR, base, and prime editing. I can promise you that we’re prepared to act immediately on what we learn. Tools are in place to drive research forward: cell lines made from A-T kids, post-mortem brain tissue samples, in vitro assays, animal models, data platforms, neuroimaging, biomarkers, wearable devices, clinical scales, and natural history studies. This meeting will also guide our funding priorities. Please help us by sharing this post with your network and encouraging any friends involved in gene therapy to join us in Boston Nov 19-20. They should reach out to Jennifer Thornton at?[email protected]?to learn more. Thanks for helping us move closer to treatments for kids with A-T!
Longwood Healthcare Leaders转发了
It was a pleasure to join Marcus, Kailash and Christoph for this thoughtful conversation on the future of R&D. I share Marcus’s excitement about the potential of AI and other technological advances to transform biomedicine, and I look forward to seeing how we as an industry can harness its potential to reimagine medicine together.
Forging the Future: Can we unite industries for truly transformative innovations? What an exciting chat at the Boston CEO! It was a privilege to engage in a dynamic conversation with Fiona H. Marshall, President of Biomedical Research at Novartis, moderated by Kailash Swarna, Managing Director at Accenture, and Christoph Westphal, General Partner at the Longwood Fund. This was the Longwood Healthcare Leaders meeting that brought together over 200 industry leaders, including C-suite executives, R&D heads, academic researchers, and life science investors. We delved into the core of sustainable R&D, exploring the transformative power of partnerships in driving genuine innovation and creation. How can we cultivate and sustain collaborations to develop superior health solutions, moving beyond competition to collective progress? We also explored core values and pivotal strategic decisions that have allowed Novo Nordisk to maintain its innovative edge over the years. Moreover, we contemplated the crucial role of R&D in ensuring accessibility to groundbreaking pharmaceuticals, addressing the vital need for equitable healthcare access. It’s impossible to know what is in the future but leveraging our current knowledge and the latest data science advancements, we looked ahead and reflected jointly on how the landscape will evolve, and how can the convergence of technology and biopharma unleash the potential of AI in drug discovery and development? This is an exciting journey, and we are at the forefront of shaping the future. I am truly energized by the insights shared amongst the participants. Hopefully, this is just the beginning of a transformative era, one where collaboration and innovation will redefine the very fabric of healthcare. Watch this space for the remarkable evolution that awaits us! #Innovation #Collaboration #longwoodhealthcareleaders #BostonCEO
Longwood Healthcare Leaders转发了
Very productive meeting in Boston at the Longwood Healthcare Leaders CEO Forum last week! The panel discussion around enabling technologies really highlighted the power of multi-omics, AI, clinical data and partnerships between industry and academia to build robust pipelines to help patients! Pleased to share the stage with amazing founders like Hanadie Yousef, Jason Cole and innovators like Kai Wucherpfennig! Thanks for the great discussion Chandra Ramanathan!
Longwood Healthcare Leaders转发了
Earlier this week, our Chief Medical Officer, Camille Bedrosian, MD, joined a thought-provoking panel at the Longwood Healthcare Leaders Boston CEO Meeting that explored innovation in clinical trials and highlighted the vital role of patient-centricity. At Amylyx, our commitment to communities with high unmet needs drives us, and prioritizing their perspectives in our clinical trials is essential to driving meaningful progress and innovation. A sincere thank you to Longwood Healthcare Leaders and everyone who contributed to this impactful event.